References
- Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149–2155.
- Raij L, DeMaster EG, Jaimes EA. Cigarette smoke-induced endothelium dysfunction: role of superoxide anion. J Hypertens. 2001;19:891–897.
- Parikh SS, Jacono AA. Deep-plane face-lift as an alternative in the smoking patient. Arch Facial Plast Surg. 2011;13:283–285.
- Eaton JB, Peng JH, Schroeder KM, et al. Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells. Mol Pharmacol. 2003;64:1283–1294.
- Kapoor S. Varenicline and its role in smoking cessation. Prev Cardiol. 2008;11:168–171.
- Tapper AR, McKinney SL, Nashmi R, et al. Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science. 2004;306:1029–1032.
- Umeda A, Kato T, Yamane T, et al. Does smoking cessation with varenicline worsen vascular endothelial function?. BMJ Open. 2013;3:e003052.
- Karayel H, Kaya B, Caydere M, et al. Prevention of unfavourable effects of cigarette smoke on flap viability using botulinum toxin in random pattern flaps: An experimental study. Plast Surg (Oakv). 2015;23:177–182.
- Black CE, Huang N, Neligan PC, et al. Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1097–R1104.
- Gomes HC, Oliveira Campos HJ, Ferreira LM, et al. Experimental model to study the effect of nicotine in a random skin flap, in the rat. Acta Cir Bras. 2004;19:65–68.
- Rinker B, Fink BF, Barry NG, et al. The effect of calcium channel blockers on smoking-induced skin flap necrosis. Plast Reconstr Surg. 2010;125:866–871.
- Gazzalle A, Teixeira LF, Pellizzari AC, et al. Effect of side-stream smoking on random-pattern skin flap survival in rats. Ann Plast Surg. 2014;72:463–466.
- Shah A, Pfaff MJ, Assi R, et al. PDE-5 inhibition improves skin flap viability in rats that are exposed to nicotine. Microsurgery 2014;34:390–397.
- Kato T, Umeda A, Miyagawa K, et al. Varenicline-assisted smoking cessation decreases oxidative stress and restores endothelial function. Hypertens Res. 2014;37:655–658.
- McFarlane RM, Deyoung G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg. 1965;35:177–182.
- Abramov Y, Golden B, Sullivan M, et al. Histologic characterization of vaginal vs. abdominal surgical wound healing in a rabbit model. Wound Repair Regen. 2007;15:80–86.
- Nacak U, Calis M, Atilla P, et al. Extracorporal shock wave therapy as a delay procedure to improve viability of zone 4: An Experimental Study in a Rat TRAM Flap Model. Ann Plast Surg. 2016;77:e15–e20.
- Vanhoutte PM. Endothelium and control of vascular function. State of the art lecture. Hypertension. 1989;13:658–667.
- Lee J, Cooke JP. Nicotine and pathological angiogenesis. Life Sci. 2012;91:1058–1064.
- Heeschen C, Weis M, Aicher A, et al. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest. 2002;110:527–536.
- Mihalak KB, Carroll FI, Luetje CW. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol. 2006;70:801–805.
- Iida M, Iida H, Takenaka M, et al. Preventive effect of varenicline on impairment of endothelial function in cerebral vessels induced by acute smoking in rats. J Anesth. 2012;26:928–931.
- Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840–844.
- Higashi Y, Noma K, Yoshizumi M, et al. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411–418.